Clinical Guides
Ménière’s Disease
A clinically focused guide to diagnosing Ménière’s disease from recurrent audiovestibular attacks, excluding dangerous mimics, and making cautious, safety-focused treatment decisions in Indian care settings.
MedNext Academy | 12 min read
Ménière’s Disease
A clinically focused guide to diagnosing Ménière’s disease from recurrent audiovestibular attacks, excluding dangerous mimics, and making cautious, safety-focused treatment decisions in Indian care settings.
Summary
Ménière’s disease is an episodic inner-ear disorder characterised by spontaneous vertigo attacks with fluctuating aural symptoms and sensorineural hearing loss. It is not simply ‘dizziness with tinnitus’. The Bárány consensus defines definite disease by at least two spontaneous vertigo episodes lasting 20 minutes to 12 hours, audiometrically documented low- to medium-frequency sensorineural hearing loss in the affected ear on at least one occasion, fluctuating aural symptoms, and no better vestibular diagnosis. Probable disease is broader: recurrent vertigo or dizziness lasting 20 minutes to 24 hours with fluctuating aural symptoms.
The diagnosis evolves over time. A patient may be investigated after a first attack without yet meeting definite criteria, while a person with recurrent labelled ‘Ménière’s’ may later prove to have vestibular migraine, BPPV, autoimmune inner-ear disease, stroke/TIA, vestibular schwannoma, perilymph fistula or another condition. The clinical task is to characterise attacks, hearing trajectory and neurological signs, obtain an audiogram, rule out meaningful mimics and preserve safety. Treatments aim to reduce attack burden and protect function; neither salt restriction nor a procedure guarantees disease control or hearing preservation.
The label should never obscure acute safety. During an attack, the immediate decision is whether this resembles the patient’s established, self-limited pattern or an acute vestibular or neurological emergency. A documented diagnosis does not exclude stroke, sudden sensorineural hearing loss, drug toxicity or a second vestibular disorder. Track vertigo, hearing, tinnitus, falls and quality of life over time; these outcomes, not a treatment name, determine whether the plan is helping. [Bárány diagnostic criteria, abstract; AAO-HNS guideline, KAS1 and KAS16]
How Common Is It?
Prevalence estimates vary widely because older studies used different criteria, surveillance is incomplete, and mild or early disease can be mistaken for migraine or non-specific dizziness. It is therefore more honest to avoid a single global or Indian prevalence figure unless the source, criteria and denominator are stated. Ménière’s disease is uncommon compared with benign positional vertigo, vestibular migraine and non-specific dizziness, but its episodic, unpredictable nature can cause disproportionate disability through falls, work disruption, hearing loss, tinnitus and anxiety about the next attack.
The condition usually presents in adulthood, but age alone neither confirms nor excludes it. Bilateral symptoms can occur over time and demand reconsideration of the differential. In India, published access to serial audiometry, vestibular physiotherapy, intratympanic treatment, MRI and neurotology is uneven; that is a service reality, not evidence that a patient has advanced disease. Do not quote foreign prevalence as an Indian rate or infer a district-level service capacity from this guide. The AAO-HNS guideline targets adults with suspected definite or probable disease and emphasises accurate work-up over routine unindicated testing. [AAO-HNS Ménière’s guideline, scope and purpose; Bárány diagnostic criteria, abstract]
Risk Factors
The cause of Ménière’s disease is incompletely understood. Endolymphatic hydrops is associated with the syndrome but is not a stand-alone clinical diagnosis. Family history may be relevant, and allergies, migraine, autoimmune factors, head injury and viral hypotheses are sometimes discussed, but none is a sufficient causal explanation for an individual attack. Avoid telling a patient that stress, salt, caffeine, alcohol or a single food ‘caused’ Ménière’s; these may be personally relevant triggers or management targets, but evidence and response vary.
Risk assessment should instead focus on vulnerability to harm during attacks: recent falls, driving, working at height or near machinery, caring for a child alone, swimming, operating vehicles, poor vision, sedating medicines, alcohol, frailty and coexisting neurological disease. Ask about migraine phenotype, vascular risk, autoimmune symptoms, recent ear surgery/trauma, ototoxic exposures and family hearing loss because they may point elsewhere. A unilateral progressive hearing asymmetry, persistent imbalance between attacks, pulsatile tinnitus or focal neurological symptoms are not ‘risk factors’ for Ménière’s; they are reasons to reconsider diagnosis and referral urgency. [AAO-HNS guideline, KAS2, KAS3 and KAS4; Bárány diagnostic criteria, definite/probable distinctions]
Diagnosis
History
Ask the patient to describe an attack without supplying the word vertigo. Establish a false spinning sensation versus light-headedness, duration, spontaneous versus positional onset, frequency, recovery, nausea/vomiting, falls and triggers. Record unilateral fullness, roaring tinnitus, muffled hearing and whether these fluctuate before, during or after attacks. Ask about migraine headache, photophobia, phonophobia, aura, positional seconds-long attacks, hearing decline between episodes, head trauma, otorrhoea, infection, new medicines and vascular/neurological symptoms. A contemporaneous attack diary with duration, hearing change, migraine features, rescue medicine and unsafe activity may be more reliable than a single recollection months later.
Examination
Examine during and between attacks where possible. Check otoscopy, hearing screen, spontaneous/gaze-evoked nystagmus, gait, Romberg, cerebellar signs, cranial nerves and a focused cardiovascular/neurological examination. Acute sustained vertigo with new central neurological signs is a stroke pathway, not an outpatient Ménière work-up. Normal examination between attacks does not exclude an episodic vestibular disorder.
Investigations
Obtain an audiogram in every suspected case; fluctuating low- to mid-frequency sensorineural loss supports definite criteria. MRI of the internal auditory canal/posterior fossa may be offered when there is audiometrically verified asymmetric sensorineural hearing loss, primarily to exclude other pathology. Routine vestibular function testing and electrocochleography are not recommended solely to establish the diagnosis. Tests should answer a question: audiometry documents hearing, MRI evaluates asymmetry, and targeted blood tests are for a credible alternative diagnosis. Repeat audiometry is useful when symptoms or communication change because a single normal test outside an attack does not capture every fluctuation. [AAO-HNS guideline, KAS1-KAS5; Bárány diagnostic criteria, abstract]
Differential Diagnosis
Vestibular migraine is a major mimic and should be actively assessed: migraine history or migrainous features during attacks can coexist with ear symptoms, and a person may have both conditions. BPPV usually produces brief, position-triggered vertigo lasting seconds rather than 20-minute-to-hour spontaneous episodes and does not explain fluctuating sensorineural hearing loss. Vestibular neuritis causes sustained acute vertigo over days, usually without cochlear symptoms. Panic, orthostatic hypotension and arrhythmia cause other forms of dizziness and should not be re-labelled as inner-ear disease without a careful history.
Dangerous alternatives include posterior-circulation stroke/TIA, especially abrupt acute vestibular syndrome with central signs, severe headache, dysarthria, diplopia, weakness, numbness or inability to walk; urgent neurological evaluation takes precedence. Consider vestibular schwannoma or other retrocochlear lesion with progressive unilateral/asymmetric hearing loss, autoimmune inner-ear disease with rapidly progressive bilateral loss, otosyphilis where epidemiology suggests it, perilymph fistula after barotrauma/trauma, and superior canal dehiscence with sound/pressure-induced symptoms. Persistent unilateral tinnitus, otorrhoea, severe ear pain or conductive loss point away from uncomplicated Ménière’s. [AAO-HNS guideline, KAS2-KAS5; Bárány diagnostic criteria, requirement for no better account]
Management
During an attack, prioritise a safe place to sit or lie down, supervision if needed, hydration after vomiting and prevention of falls. A brief course of vestibular suppressants may be offered only during attacks; prolonged use can impair central compensation and cause sedation. Patients should have a written plan for red flags and for getting home without driving. Between attacks, educate about the episodic course, hearing fluctuation, communication strategies and realistic treatment goals.
The AAO-HNS guideline recommends education on diet and lifestyle modifications that may reduce symptoms, but evidence does not support presenting a low-salt, caffeine-free or alcohol-free plan as a universal cure. Make any trial specific, feasible and reviewed against attack frequency, hearing and quality of life. Maintenance oral diuretics and/or betahistine may be offered as options, recognising that supporting evidence and regulatory availability vary. Vestibular rehabilitation helps chronic imbalance, not the acute spinning attack. Hearing assistive technology and counselling should be offered when hearing loss affects communication.
For persistent active disease despite non-invasive care, intratympanic steroid can be considered; intratympanic gentamicin is an option after non-ablative therapy, but its vestibulotoxic intent and hearing/balance trade-off require specialist counselling. Before an ablative step, clarify whether the other ear hears well, whether chronic imbalance or falls already limit independence, and whether the patient can access rehabilitation. Labyrinthectomy is for selected patients with non-usable hearing after less destructive options. [AAO-HNS guideline, KAS7-KAS14]
Prescribing Information
Vestibular suppressants and antiemetics can reduce distress during a severe attack, but prescribe the smallest effective quantity for short attack-only use. Sedation, impaired reaction time, falls, confusion, anticholinergic effects, alcohol interaction and dependence risk matter, especially in older adults and anyone driving or working at height. They are not maintenance medicines for daily dizziness. Review pregnancy, glaucoma, prostate symptoms, cardiac rhythm issues, renal/hepatic impairment and concurrent sedatives before selecting an agent.
Betahistine and diuretics are optional maintenance approaches in AAO-HNS guidance, not diagnostic tests and not guarantees of hearing preservation. Betahistine’s licensing and supply differ between jurisdictions; do not assume an Indian product, indication or dose. Diuretics need blood pressure, electrolytes, renal function, gout and interaction review, particularly with ACE inhibitors, ARBs, lithium or other antihypertensives. Intratympanic steroids/gentamicin are specialist procedures, not office refills. Gentamicin may control vertigo by vestibular ablation but can worsen imbalance and carries hearing risk; a patient’s contralateral-ear hearing and occupational safety materially affect the decision. [AAO-HNS guideline, KAS7-KAS12; AAO-HNS guideline scope statement]
When to Refer
Refer urgently to emergency/neurology services for acute vertigo with new focal neurological deficit, severe ataxia, inability to sit or stand unsupported, new severe headache, neck pain after trauma, loss of consciousness, chest pain, or a concerning arrhythmia/orthostatic pattern. Sudden sensorineural hearing loss is time-sensitive and needs urgent ENT/audiology assessment; it should not wait for several recurrent episodes to ‘prove’ Ménière’s. A suspected labyrinthitis with systemic toxicity, mastoid symptoms or meningism also needs urgent assessment.
Refer routinely but promptly to ENT/audiology for recurrent spontaneous vertigo with aural symptoms, any documented asymmetric sensorineural hearing loss, progressive unilateral hearing loss, persistent tinnitus, diagnostic uncertainty, falls, work-safety impact or failure of a conservative management trial. Neurology input is appropriate where vestibular migraine, TIA/stroke or another central disorder is plausible. Neurotology/tertiary referral is appropriate before gentamicin, endolymphatic surgery or ablative procedures, particularly in bilateral disease or a sole-hearing ear. Referral documentation should include attack duration, audiograms, migraine screen, medicines, safety incidents and the question being asked. [AAO-HNS guideline, KAS2-KAS5 and KAS11-KAS12]
Red Flags
Do not diagnose Ménière’s in an acute vestibular syndrome with focal neurological signs, diplopia, dysarthria, dysphagia, weakness, numbness, new severe headache, inability to walk independently, altered consciousness or significant new neck pain. These features can signal central pathology and require emergency assessment. Continuous severe vertigo lasting days is also not the usual 20-minute-to-12-hour definite-Ménière attack pattern, although a person with established disease can have another illness.
Urgent ENT/audiology review is needed for sudden hearing loss, rapidly progressive unilateral or bilateral hearing loss, severe persistent tinnitus with asymmetry, facial weakness, otorrhoea, severe otalgia, post-traumatic vertigo/hearing loss, or recurrent vomiting causing dehydration. Safety red flags include an attack while driving, falls, near-drowning, work at heights or unsafe use of sedating rescue medicines. During an attack, the immediate advice is not to drive, climb, swim alone or operate machinery; the longer-term fitness-to-drive decision must be individualised and checked against current local licensing requirements, not guessed from an overseas guideline. [AAO-HNS guideline, KAS1-KAS5 and KAS14; Bárány diagnostic criteria, episode-duration limits]
Indian Clinical Context
This guide uses international diagnostic and management guidance because a current India-specific Ménière’s disease clinical guideline was not identified among the sources cited here. It must not be mistaken for an Indian medicine label, insurance rule, disability certificate standard or driving-law interpretation. Audiometry is the essential diagnostic test in the AAO-HNS pathway; where serial audiology, MRI, vestibular rehabilitation or intratympanic therapy is inaccessible, document the uncertainty and refer rather than calling symptoms ‘Ménière’s’ from tinnitus alone.
India-specific planning is practical: establish how the patient will travel safely during attacks, whether work involves two-wheelers, commercial driving, heights, water or machinery, and whether family support and emergency transport are available. Ask about over-the-counter sedatives, traditional remedies and diuretics without judgement, because adverse effects and interactions may be clinically important. Tailor hearing rehabilitation to language, cost and the local availability of audiology/ENT services. Do not promise betahistine availability or claim that salt restriction has proven benefit for an individual. The safest jurisdictional advice is to counsel immediate attack-related driving avoidance and direct the patient to their treating clinician and current local licensing authority for ongoing restrictions. [AAO-HNS guideline, KAS7-KAS14; NMC CBME Curriculum 2024, patient safety and communication domains]
NMC Competency Mapping
Ménière’s disease links NMC outcomes in ENT, physiology, pharmacology, medicine, neurology, radiology, rehabilitation and AETCOM. At Know level, learners should distinguish vertigo from non-vestibular dizziness, state the defining temporal/audiometric features of definite and probable disease, and list BPPV, vestibular migraine, vestibular neuritis, stroke/TIA and retrocochlear pathology as important alternatives. At Know How level, they should take an audiovestibular history, perform otoscopy and focused neurological examination, request an audiogram, recognise asymmetric sensorineural loss, and explain why MRI may be used selectively.
At Show How level, a learner should safety-net a vertigo attack, document falls/driving risk, counsel on brief rescue-medicine use and assistive hearing options, and communicate diagnostic uncertainty without labelling every dizzy patient. They should not independently interpret complex vestibular tests, prescribe long-term diuretics without monitoring, give intratympanic therapy, or decide fitness to drive. AETCOM includes eliciting occupational consequences, respecting fear of sudden attacks, and making a shared decision where a vertigo-controlling procedure may sacrifice residual function. [NMC CBME Curriculum 2024, ENT, medicine, pharmacology, radiology, rehabilitation and AETCOM sections]
Key Exam Pearls for NEET PG
Definite Ménière’s disease requires at least two spontaneous vertigo episodes lasting 20 minutes to 12 hours, low- to mid-frequency sensorineural hearing loss documented by audiometry, fluctuating aural symptoms and exclusion of a better diagnosis. Probable disease allows 20-minute-to-24-hour vertigo/dizziness episodes with fluctuating aural symptoms. Audiometry is essential; electrocochleography and routine vestibular testing are not required simply to make the diagnosis.
Vestibular migraine is an important mimic. BPPV causes brief position-triggered attacks and usually no fluctuating sensorineural hearing loss. Persistent acute vertigo with central neurological signs is a stroke pathway, not Ménière’s. MRI is considered when asymmetric sensorineural hearing loss needs evaluation for alternative pathology. Sudden hearing loss needs urgent ENT/audiology assessment.
Use vestibular suppressants only briefly during attacks, not as daily chronic therapy. Diet/lifestyle trials may be discussed but evidence does not justify cure claims. Diuretics or betahistine are optional maintenance options with monitoring and access limitations. Intratympanic steroids may be used for persistent active disease; gentamicin and labyrinthectomy require specialist selection because vertigo control can trade off against vestibular/hearing function. [AAO-HNS guideline, KAS1-KAS14; Bárány diagnostic criteria, abstract]
Frequently Asked Questions
Can Ménière’s disease be diagnosed from vertigo and tinnitus alone?
No. Tinnitus and vertigo are common and have many causes. Definite Ménière’s disease requires recurrent spontaneous attacks of the appropriate duration, fluctuating aural symptoms, audiometrically documented low- to mid-frequency sensorineural hearing loss and no better explanation. An early patient may have a possible or probable syndrome rather than a final diagnosis. Audiometry, a migraine screen, neurological examination and selective MRI for asymmetric hearing loss make the assessment safer.
Should patients permanently stop salt, caffeine and alcohol after diagnosis?
A clinician may discuss diet and lifestyle changes as an individual trial, but no universal restriction reliably cures Ménière’s disease. An overly rigid plan can add burden without benefit. Agree one or two feasible changes, record attack frequency, hearing and quality of life, then reassess. The most important immediate safety measures during an attack are to stop hazardous activity, avoid driving and obtain help if severe vomiting, falls or neurological symptoms occur. Nutrition and coexisting medical conditions still matter. If a trial is unhelpful, stop it rather than escalating restriction indefinitely.
Are betahistine and diuretics proven to prevent hearing loss?
They are options in the AAO-HNS guideline for maintenance treatment, not guaranteed disease-modifying therapy. Evidence is limited, responses differ and availability, labels and monitoring requirements vary. Diuretics can disturb electrolytes or renal function and interact with other medicines; betahistine should not be assumed appropriate or available in every jurisdiction. The decision should be reviewed against attacks, hearing, side effects, falls risk and the person’s work and driving responsibilities rather than continued indefinitely by default.
When should a person with episodic vertigo avoid driving or seek urgent help?
Do not drive, ride a two-wheeler, climb, swim alone or operate machinery during an attack or while sedated by a rescue medicine. Seek emergency assessment for weakness, numbness, speech or vision change, severe new headache, inability to walk, loss of consciousness, chest pain or sustained severe vertigo unlike usual attacks. Sudden hearing loss also requires urgent ENT/audiology review. Long-term driving restrictions are individual and jurisdiction-specific, so the patient should obtain current advice from their treating clinician and applicable licensing authority.
Inside MedNext for this topic
- 411 MedNext-authored chapters
- 80,000+ MCQ bank
- 15 study modes
- a growing library of visual revision sheets
Study modes
- Notes
- MCQ
- Audio
- Video
- Visual
- 3D Anatomy
- Trace
- Flashcards
- Mnemonics
- Image Bank
- Clinical
- Microscopy
- Audio QBank
- Cadaver
- Book Match
Continue reading
Clinical GuidesAll Clinical Guides
Browse all clinical management guides for Indian medical practice.
Test your knowledge
Attempt structured MCQs on this topic to consolidate your understanding and connect the guide to exam-focused practice.
Try MCQs on this topic